Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Non-Current Assets (2018 - 2025)

Dna X's Non-Current Assets history spans 8 years, with the latest figure at $15.0 million for Q4 2025.

  • Quarterly results put Non-Current Assets at $15.0 million for Q4 2025, up 97.9% from a year ago — trailing twelve months through Dec 2025 was $42.9 million (down 12.46% YoY), and the annual figure for FY2025 was $15.0 million, up 97.9%.
  • Non-Current Assets for Q4 2025 was $15.0 million at Dna X, up from $9.9 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $15.3 million in Q3 2024 to a low of $710000.0 in Q1 2021.
  • The 5-year median for Non-Current Assets is $9.0 million (2025), against an average of $8.7 million.
  • The sharpest move saw Non-Current Assets tumbled 47.29% in 2021, then soared 671.83% in 2022.
  • Year by year, Non-Current Assets stood at $2.4 million in 2021, then skyrocketed by 189.49% to $6.9 million in 2022, then surged by 78.63% to $12.3 million in 2023, then crashed by 38.2% to $7.6 million in 2024, then skyrocketed by 97.9% to $15.0 million in 2025.
  • According to Business Quant data, Non-Current Assets over the past three periods came in at $15.0 million, $9.9 million, and $9.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.